$AGN Company News Paulson takes stake in Abbvie, adds

New Post Public Reply Private Reply Replies (0) Message Board

Nov 15, 2014 at 10:02 AM

$AGN Company News

Paulson takes stake in Abbvie, adds to Shire holdings 6:46 p.m. Nov. 14, 2014 - MarketWatch
If you're looking big pharma, look no further than Actavis 1:05 p.m. Nov. 13, 2014 - The Trading Deck
Aegon profit hit by mortality changes 2:14 a.m. Nov. 13, 2014 - MarketWatch.com
Drug companies Salix, Intercept reeling after earnings, drama 12:15 p.m. Nov. 7, 2014 - Russ Britt
Ackman urges Allergan to open sale process, negotiate 10:33 a.m. Nov. 7, 2014 - Chelsey Dulaney
Bill Ackman scores critical win in Valeant-Allergan takeover war 4:23 p.m. Nov. 4, 2014 - Russ Britt
Regeneron skids on shortfall in Eylea sales 11:15 a.m. Nov. 4, 2014 - Russ Britt
4 more ‘Amazon’ stocks you may want to avoid 8:43 p.m. Oct. 27, 2014 - Philip van Doorn
Twitter shares drop in wake of quarterly results 5:07 p.m. Oct. 27, 2014 - Sue Chang
Energy stocks sap S&P 500 4:22 p.m. Oct. 27, 2014 - Barbara Kollmeyer
Allergan shares advance 1.1% 9:31 a.m. Oct. 27, 2014 - Sue Chang
Allergan board skeptical of Valeant's offer to improve bid 9:28 a.m. Oct. 27, 2014 - Ciara Linnane
Allergan board says would consider an increased Valeant offer 9:13 a.m. Oct. 27, 2014 - Ciara Linnane
‘Monsters under the bed’ threaten market’s seasonal boost 9:09 a.m. Oct. 27, 2014 - Shawn Langlois
4 warnings for companies after Amazon’s spectacular loss 8:30 a.m. Oct. 27, 2014 - Marek Fuchs
Allergan raises outlook, Valeant may improve bid 7:48 a.m. Oct. 27, 2014 - MarketWatch.com
Allergan shares up 3.1% in premarket trade 7:14 a.m. Oct. 27, 2014 - Ciara Linnane
Valeant willing to improve Allergan offer to value of at least $200 a share 7:11 a.m. Oct. 27, 2014 - Ciara Linnane
Valeant urges Allergan board to take control of process 6:57 a.m. Oct. 27, 2014 - Ciara Linnane
Valeant says willing to improve Allergan offer to value of at least $200 a share 6:57 a.m. Oct. 27, 2014 - Ciara Linnane

Halliburton Turns Hostile on Baker Hughes 9:53 p.m. Nov. 14, 2014 - The Wall Street Journal Interactive Edition
Valeant Should Drop Allergan Bid And Go For Zoetis 8:30 a.m. Nov. 14, 2014 - Seeking Alpha
Expect More Specialty Pharma Deals 7:40 a.m. Nov. 14, 2014 - Barrons.com
Will Actavis Snatch Allergan, Valeant Settle for Zoetis? - Analyst Blog 5:28 p.m. Nov. 13, 2014 - Zacks.com
Ackman's Pershing Group Buys Stake in Zoetis 10:23 a.m. Nov. 13, 2014 - GuruFocus.com
Valeant, Allergan Fight for Doctors 7:45 p.m. Nov. 12, 2014 - The Wall Street Journal Interactive Edition
Gilead Reports Promising Data on its HCV Drug Harvoni - Analyst Blog 5:00 p.m. Nov. 12, 2014 - Zacks.com
Analyst: Bill Ackman's Zoetis Move Casts Doubt On Allergan Bid 3:04 p.m. Nov. 12, 2014 - benzinga.com
3 Stocks Moving The Drugs Industry Upward 12:25 p.m. Nov. 12, 2014 - TheStreet.com
Actavis closing in on Allergan 12:22 p.m. Nov. 12, 2014 - Seeking Alpha
Actavis, Allergan Reported Near Deal As Valeant Lurks 11:43 a.m. Nov. 12, 2014 - Investors Business Daily
Regeneron/Sanofi Announce Positive Dupilumab Study Data - Analyst Blog 11:00 a.m. Nov. 12, 2014 - Zacks.com
Allergan Spikes Higher On Acquisition Report 9:45 a.m. Nov. 12, 2014 - benzinga.com
Allergan tweaks bylaws pertaining to special meeting requests 8:07 a.m. Nov. 12, 2014 - Seeking Alpha
Tracking The Parnassus Core Equity Fund 7:45 a.m. Nov. 12, 2014 - Seeking Alpha
Mergers and Acquisitions: Zoetis a Buy on Ackman Stake 3:12 a.m. Nov. 12, 2014 - InvestorPlace.com
Bristol-Myers Gives Updates on HCV Candidate Daclatasvir - Analyst Blog 6:41 p.m. Nov. 11, 2014 - Zacks.com
Dendreon Shares Plummet After It Files for Bankruptcy - Analyst Blog 4:45 p.m. Nov. 11, 2014 - Zacks.com
Ackman Takes Stake in Animal-Health Company 4:25 p.m. Nov. 11, 2014 - The Wall Street Journal Interactive Edition
Zoetis could be fallback option for Valeant 4:16 p.m. Nov. 11, 2014 - Seeking Alpha

Physicians Continue to Voice Strong Support for Allergan via Open Letters to the Eye Care Community 9:00 a.m. Nov. 14, 2014 - BusinessWire - BZX
FDA Approves New Styles of Allergan’s NATRELLE® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants 4:50 p.m. Nov. 12, 2014 - BusinessWire - BZX
Allergan Board of Directors Announces Approval of Amendments to Company’s Bylaws 7:02 a.m. Nov. 12, 2014 - BusinessWire - BZX
New Survey Reveals What Women in the U.S. Really Want to Know About BOTOX® Cosmetic (onabotulinumtoxinA) 8:47 a.m. Nov. 11, 2014 - PR Newswire - PRF
Ad hoc: Biofrontera to take over the sales and marketing of Ameluz(R) in Spain from Allergan 3:20 a.m. Nov. 7, 2014 - Thomson Reuters ONE
New Survey Shows Nearly 60% Of Women Say They Would Rather Have A More Youthful Looking Face Than A More Youthful Looking Body(1) 4:25 p.m. Nov. 5, 2014 - PR Newswire - PRF
Ipsen Biopharmaceuticals, Inc. Announces Hire of Donald Pearl as Vice President of Neurology 9:37 a.m. Nov. 5, 2014 - BusinessWire - BZX
Allergan Comments on California Federal Court Ruling in Insider Trading Lawsuit against Valeant & Pershing Square 1:56 p.m. Nov. 4, 2014 - BusinessWire - BZX
Valeant And Pershing Square May Vote At Special Meeting 1:27 p.m. Nov. 4, 2014 - PR Newswire - PRF
Quarterly Financial & Operational Results Release and Dividends - Research Reports on AFLAC, BlackRock, Allergan, Cabot and Cheniere Energy 8:40 a.m. Nov. 3, 2014 - PR Newswire - PRF
Allergan Canada Launches a 3D JUVEDERM(R) Visualization iPad App Powered by ModiFace 9:02 a.m. Oct. 29, 2014 - Marketwired
Allergan Comments on Valeant Letter 9:10 a.m. Oct. 27, 2014 - BusinessWire - BZX
Allergan Announces Quarterly Conference Call 1:00 p.m. Oct. 24, 2014 - BusinessWire - BZX
Global Pediatric Drugs and Vaccines Market 5:08 p.m. Oct. 23, 2014 - PR Newswire - PRF
Global Botulinum Toxin Market 4:17 p.m. Oct. 23, 2014 - PR Newswire - PRF
New Solution for Patients, Quarterly Financial Results, Clinical Study Initiation, Merger Updates, and Product Launch - Research Reports on CVS, Valeant, Regeneron, Allergan and Agilent 9:20 a.m. Oct. 23, 2014 - PR Newswire - PRF
Principled Equity Market Fund (PEQKL) Performance Close to Benchmark through Third Quarter of the Year 2:05 p.m. Oct. 22, 2014 - BusinessWire - BZX
Pharma Stocks Technical Data - Allergan, Zoetis, Actavis, Avanir Pharma, and Mallinckrodt 8:40 a.m. Oct. 20, 2014 - PR Newswire - PRF
Harvard Business Review Ranks David Pyott One of the Top 5 CEOs in the World 8:02 a.m. Oct. 15, 2014 - BusinessWire - BZX
Allergan Provides Update on Earnings Per Share and Sales Expectations 6:45 a.m. Oct. 9, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Employment Law Suit Hits ABC: Alleged Wage Violations

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Layne's Chicken Fingers Expands with Brownsville Opening

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

EFICYENT Ventures to Connect at Singapore FinTech Fest

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

KINGRVER Boosts RV Comfort with New Water Heater Lineup

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...